article · British Journal of Biomedical Science
<b>Background</b>: As hepatocellular carcinoma (HCC) arising from chronic hepatitis C virus (HCV) infection in liver cirrhosis is a major problem in public health, early and rapid prediction of HCC is urgent. We hypothesized that a single nucleotide polymorphism in the <i>Apa1</i> SNP in the vitamin D receptor may help diagnosis.<b>Methods</b>: We recruited 3 groups: 80 HCC patients with HCV cirrhosis, 80 HCV cirrhotic patients free of HCC and 80 healthy controls. <i>Apa1</i> rs7975232 SNP was detected by PCR- RFLP technique. Routine laboratory markers were determined by standard methods.<b>Results</b>: The Apa1 CC genotype was more frequent (75%) in HCC than in the cirrhosis (35%) and control (20%) groups (<i>P</i><0.0001). CC patients were more likely to have a more severe Child-Pugh score (<i>P</i>=0.027) and MELD score (<i>P</i><0.05). In multivariate analysis, the CC genotype out-performed AFP is determining HCC.<b>Conclusion</b>: Apa1 CC genotype is linked to HCC in HCV C cirrhotic patients, and so has the potential to be an independent biomarker predictor for HCC occurrence in HCV cirrhosis.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1080/09674845.2019.1680166
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.